Actionnariat et activité des initiés pour Replimune Group, Inc. (REPL): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $12.96 |
| Capitalisation | $1.1B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-20 | Astley-Sparke Philip | G-Gift | 50,000 | |
| 2026-08-17 | Hill Emily Luisa | S-Sale | 9,256 | $132K |
| 2026-08-10 | Patel Sushil | S-Sale | 39,341 | $510K |
| 2026-08-10 | Hill Emily Luisa | S-Sale | 11,448 | $148K |
| 2026-08-10 | Xynos Konstantinos | S-Sale | 11,447 | $148K |
| 2026-08-10 | Schwendenman Andrew | S-Sale | 7,632 | $99K |
| 2026-08-11 | BAKER BROS. ADVISORS LP | P-Purchase | 2,609,946 | $261 |
| 2026-08-11 | BAKER BROS. ADVISORS LP | P-Purchase | 126,394 | $13 |
| 2026-06-01 | Sarchi Christopher | S-Sale | 12,000 | $111K |
| 2026-05-18 | Xynos Konstantinos | S-Sale | 14,023 | $71K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $20.6M | $17.6M | $25.7M | $59.5M | $182.5M | $105.9M | $146.6M | $74.5M | $111.1M | $209.0M |
| Placements à Court Terme | 0 | $44.0M | $109.1M | $109.1M | $293.8M | $289.7M | $436.8M | $346.2M | $372.7M | $59.9M |
| Créances | $1.4M | $2.4M | $2.5M | $3.0M | $3.0M | $3.1M | $2.9M | $4.9M | $3.7M | $1.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $22.4M | $64.7M | $141.0M | $174.3M | $483.7M | $404.0M | $592.6M | $433.7M | $495.9M | $279.1M |
| Immobilisations Corporelles | $342000 | $370000 | $12.2M | $58.2M | $57.7M | $55.6M | $52.4M | $52.4M | $52.5M | $48.6M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $22.8M | $65.2M | $154.3M | $234.1M | $543.1M | $461.2M | $646.6M | $487.7M | $551.3M | $332.4M |
| Dettes Fournisseurs | $323000 | $2.0M | $7.1M | $3.4M | $2.4M | $3.7M | $5.4M | $2.6M | $12.5M | $6.7M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.0M | $5.2M | $9.9M | $11.9M | $14.5M | $20.8M | $33.8M | $40.4M | $62.4M | $58.2M |
| Dette à Long Terme | 0 | 0 | 0 | $9.8M | 0 | 0 | $28.6M | $44.8M | $46.4M | $83.3M |
| Passifs Totaux | $34.3M | $93.2M | $16.5M | $50.4M | $44.4M | $50.0M | $91.3M | $113.2M | $135.5M | $166.2M |
| Réserves | -$9.2M | -$28.9M | -$59.8M | -$112.3M | -$193.2M | -$311.2M | -$485.5M | -$701.3M | -$948.6M | -$1.26B |
| Capitaux Propres | -$11.5M | -$28.1M | $137.9M | $183.7M | $498.7M | $411.2M | $555.3M | $374.5M | $415.8M | $166.2M |
| Dette Totale | 0 | 0 | $6.6M | $41.8M | $33.3M | $32.8M | $60.8M | $75.9M | $76.2M | $111.6M |
| Dette Nette | -$20.6M | -$61.6M | -$128.2M | -$126.8M | -$443.0M | -$362.8M | -$522.6M | -$344.8M | -$407.6M | -$157.3M |
| Fonds de Roulement | $20.4M | $59.5M | $131.1M | $162.4M | $469.2M | $383.2M | $558.8M | $393.2M | $433.5M | $220.9M |
Santé financière
| Dette / Capitaux propres | 1.06 |
| Ratio de liquidité | 5.23 |
Rentabilité
| Rentabilité des capitaux propres | -159.32% |
| Rentabilité du capital investi | -136.14% |
| Rentabilité des actifs | -117.65% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ARVN · ATXS · AVBP · DNA · IOVA · MBX · MGTX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de REPL: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions